Respiratory Clinical Specialist | interested in COPD, NIV, pulmonary rehab,Critical Care, Research | lover of Jesus.
London,UK
Joined March 2009
- Tweets1.4K
- Following577
- Followers480
- Likes341
Kola Akinlabi retweeted
Skeletal muscle adaptations and post-exertional malaise #PEM #PESE in #LongCOVID @RobWust
cell.com/trends/endocrinolog…
Effectiveness of Post-COVID rehabilitation and impact of frailty in Post-COVID Syndrome publications.ersnet.org/cont…
Kola Akinlabi retweeted
RESPIRATORY PHYSIOS ARE PLAYING CENTRAL ROLES AT THIS YEAR'S BRITISH THORACIC SOCIETY SUMMER MEETING
Pearlene Antoine-Pitterson, Enya Daynes and Róisín Cahalan have key roles at the British Thoracic Society event: physioupdate.co.uk/news/resp…
@roisinc1 @BTSrespiratory @EnyaDaynesPT
Great RCT!!
Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trial thorax.bmj.com/content/early…
Amazing!!
A meta-analysis of Pseudomonas aeruginosa eradication treatment in bronchiectasis reports successful eradication in 40% of cases at 12 months. The data suggest superior results with the inclusion of an inhaled antibiotic. bit.ly/3QDmIi8
Beautiful presentation by Prof Wisia Wedzicha Rhinovirus is responsible for about 56% of COPD exacerbations and about 60% is found sputum. May be it’s time to start thinking of RSV vaccines especially in the elderly and frail patients.
Primary mucoiliary dyskinesia (PCD) occurs in about 12% of people with #Bronchiectasis- diagnosis may be a key game changer in tailored interventions especially airway clearance care by #physiotherapists #BTSWinter2023 #respiratory
Kola Akinlabi retweeted
This #WorldCOPDDay I’m speaking at the All Party Parliamentary Group on Respiratory Health.
#speakupforCOPD
Kola Akinlabi retweeted
Long COVID research: an update from the PHOSP-COVID Scientific Summit @LancetRespirMed “Long COVID remains a major challenge for the millions of people who have persistent morbidity…It is imperative that long COVID remains a …research priority” thelancet.com/journals/lanre…
Kola Akinlabi retweeted
From @PHOSP_COVID:
“The planned work looking into mechanisms that drive the long-term effects of COVID-19 on all organs should help in the development of new tests, new treatments, and improved outcomes for people living with #LongCovid”
thelancet.com/journals/lanre…
If you ever wondered why chest physiotherapy in ITU just look at this my patient- a complete left lung collapse before and after chest physiotherapy CXR
Kola Akinlabi retweeted
We are looking for respiratory experts to help make 🇬🇧 #WorldCOPDDayBatonPass a success… please let us know by DM if you are in and can share on the day.
@bolton_char @ProfWilko @toplungdoc @russell_doc @SallySingh_ @MTMaddocks @MonaBafadhel @Monfletch @JuliaBott5 @lungsatwork
Clinical effectiveness of Tele-Pulmonary rehabilitation: a comparative study to face to face pulmonary rehabilitation erj.ersjournals.com/content/…
Kola Akinlabi retweeted
💨 O2 in stable #COPD & acute exacerbations? Hypoxemic SpO2 associated w ⬆️ mortality. Be cautious in targeting controlled hypoxemia (based on preH data) in settings as ICU.
📖 rdcu.be/dnEbN
Reply to
📖 rdcu.be/dnEb1
💨 Refer to
📖 rdcu.be/diyLz
